Gnomi App Corp
13.5.2024 16:46:54 CEST | ACCESS Newswire | Press release
Gnomi App launches an unprecedented paid program providing journalists with an opportunity to share their opinion and build their global audience.
LOS ANGELES, CA / ACCESSWIRE / May 13, 2024 / Today the groundbreaking Gnomi global aggregated news app, dedicated to empowering global conversations by enabling transparent information sharing, launches its Paid Journalism Program. The bold new initiative invites established independent writers, journalists, and thought leaders to share and monetize original content on the platform.
To view this piece of content from cdn.nwe.io, please give your consent at the top of this page.Gnomi App Logo
This content will complement Gnomi's core global news stream, which utilizes machine learning technology to translate news, sourced from 22 top GDP countries, into more than 11 languages in real time.
Starting today, Gnomi's Paid Journalism Program is accepting applications from experienced writers, journalists and thought leaders, who have cultivated a digital community with their expertise and are seeking avenues to share original content from their unique point of view. Writers can contribute across a broad range of categories, such as Health, Politics, Entertainment, Sports, Business, Lifestyle, Science, and more while adhering to basic community guidelines. The Gnomi team will review each application carefully and inform the applicant of their status within 2-5 business days. Once accepted, the writer can negotiate a fair rate per article.
"The media industry is facing an unprecedented crisis, with sweeping layoffs leaving talented journalists in a state of uncertainty, but Gnomi believes that great writing and the voices of talented writers should not be held back by the limitations of traditional publishing," says Eva Cicinyte, CEO and founder of Gnomi App. "We believe in the power of independent journalism and have built a cutting-edge platform that empowers writers to take control of their content, connect directly with their audience, and earn money at the same time. We're putting power back in the hands of the journalist. What better way to showcase the value of our platform? We hope to grow our Gnomi community by growing the individual audiences of a vibrant network of writers, who are passionate about storytelling."
Highlights of Gnomi's Paid Journalism Program:
- Write about topics that matter to you.
- Get paid per article.
- Amplify global reach to build your audience, your portfolio, and your brand.
- Personalize and enhance content with imagery, videos, an array of font styles and other tools that help to create a compelling story.
Link to Gnomi's Paid Journalism application: https://www.gnomi.com/journalismprogram
About Gnomi: Gnomi App is a global platform that serves as both a global news streaming service (with sources in 22 top GDP countries, translated into more than 11 languages in real time) and a publishing platform, creating an innovative space for informed discussions with a wealth of diverse perspectives. The platform formally launched on May 3, 2024.
Contact:
Tracy Paul & Company Inc
Tracy Paul
Tracy@TracyPaul.com
917-693-9139
Contact Information
Tracy Paul
Tracy Paul & Company, Inc.
tracy@tracypaul.com
917-693-9139
Related Images
SOURCE: Gnomi App Corp.
To view this piece of content from stats.nwe.io, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 15:45:00 CET | Press release
Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica
Preservica Redefines Digital Preservation with Powerful Built-In AI Tools4.2.2026 15:00:00 CET | Press release
OXFORD, UK and BOSTON, MA / ACCESS Newswire / February 4, 2026 / Preservica, the leader in AI-powered Active Digital Preservation™, today announced the rollout of integrated, human-centered AI tools and flexible AI Credits across its product editions. These new features make AI assistance a seamless part of everyday archival workflows, empowering organizations of all sizes to safely adopt AI and scale its use as their needs grow. "With the sheer volume of digital content in backlogs and being created daily, using AI to assist in archival tasks has now become essential" says Stuart Reed, Chief Product Officer at Preservica "Seamlessly integrating human-centered AI tools across our product editions turns AI for Digital Preservation into reality - enabling organizations of all sizes to accelerate routine work, cut backlogs and enhance discovery." Developed in collaboration with Preservica's user community and refined through the company's highly rated AI Workshop series, these embedded to
Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale4.2.2026 15:00:00 CET | Press release
CALGARY, AB / ACCESS Newswire / February 4, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions company, today announced that it has filed its Quarterly Report on Form 10-Q for the six months ended November 30, 2025. The filing highlights continued momentum in Karbon-X's commercial operations, driven by significant revenue growth and the expansion of its global carbon activities across both compliance and voluntary markets. "Over the past several quarters, we transformed Karbon-X from a developing platform into a scaled, revenue-generating global operator," said Chad Clovis, Chief Executive Officer of Karbon-X Corp. "Revenue increased to $56.5 million (USD), compared to $1.3 million (USD) in the prior-year period, reflecting the strength of our commercial strategy and the growing demand for high-integrity carbon solutions. As we continue to invest in scaling our operations, our expanding global footprint, improved profitability, a
Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant4.2.2026 14:00:00 CET | Press release
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 151 million grant) and, simultaneously, a new platform trial for progressive supranuclear palsy (PSP) (supported by a USD 75 million grant) SAN FRANCISCO, CA / ACCESS Newswire / February 4, 2026 / Axon Neuroscience, a global leader in immunotherapy for human neurodegenerative diseases with an internationally recognized scientific team, announces the achievement of two historic milestones with the potential to significantly influence the future treatment of Alzheimer's disease and progressive supranuclear palsy (PSP): 1. AADvac1 Selected as the First Tau Therapy in the Phase 2 Alzheimer's Tau Platform (ATP) Combination-Therapy Trial An independent panel of leading U.S. scientific and clinical experts selected AADvac1 as the first therapy targeting pathological tau protein to be evaluated in
CHAR Technologies Licenses High-Temperature Pyrolysis Technology to GazoTech SAS for Entry Into European Markets4.2.2026 14:00:00 CET | Press release
TORONTO, ON / ACCESS Newswire / February 4, 2026 / CHAR Technologies Ltd. ("CHAR Tech" or "the Company") (TSXV:YES)(FSE:68K) a leader in sustainable biomass energy solutions, today announced that it has entered into a formal technology know-how licensing agreement with GazoTech SAS ("GazoTech"), a France-based energy developer, to support deployment of CHAR Tech's technology in France and selected European markets. The agreement follows recent commissioning progress at CHAR Tech's Thorold Renewable Energy Facility and complements the Company's ongoing development of larger-scale projects in North America. Under the agreement, CHAR Tech is the licensor of its proprietary High-Temperature Pyrolysis ("HTP") technology, granting GazoTech a know-how licence for projects developed in France as well as certain additional European markets, subject to project-by-project application of the licenced technology. GazoTech has multiple projects in development in France, notably: An industrial integr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom